Go Deep
Nomura Micro Science Co., Ltd.
Nomura Micro Science Co., Ltd. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 21,422 | 30.6 | 2.82 | 1.46 | 1,713.18 |
| Oct 2026 | 21,573 | 29.8 | 2.81 | 1.46 | 1,706.28 |
| Oct 2026 | 21,575 | 29.4 | 2.81 | 1.46 | 1,702.32 |
Nomura Micro Science Co., Ltd. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 9,202,469,000.0 | 15,198,911,000.0 | 15,853,684,000.0 | 12,790,121,000.0 |
| Net Profit | 239,826,000.0 | 952,327,000.0 | 1,452,406,000.0 | 949,038,000.0 |
| EPS | 6.2 | — | — | — |
Nomura Micro Science Co., Ltd. Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 56,245,860,000.0 | 96,359,952,000.0 | 73,021,486,000.0 | 49,595,831,000.0 | — |
| Net Profit | 3,818,172,000.0 | 10,199,642,000.0 | 7,978,023,000.0 | 5,806,687,000.0 | — |
| EPS | 100.4 | 270.8 | 213.5 | 156.9 | — |
Nomura Micro Science Co., Ltd. Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Total Assets | 110,290,164,000.0 | 116,783,140,000.0 | 70,602,796,000.0 | 41,918,879,000.0 |
| Total Liabilities | 70,437,235,000.0 | 79,769,206,000.0 | 41,678,574,000.0 | 20,517,771,000.0 |
| Total Equity | 39,852,929,000.0 | 37,013,934,000.0 | 28,924,222,000.0 | 21,401,108,000.0 |
Owes vs Owns
Nomura Micro Science Co., Ltd. owed ¥0.65 for every ¥1 it owned in Jun 2026, up from ¥0.49 in Mar 2023.
| Period | Jun 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.65× | 0.64× | 0.68× | 0.59× | 0.49× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Nomura Micro Science Co., Ltd. Assets & Liabilities Breakdown (JPY millions)
What it owns — Mar 2026
Cash & short-term investments 9.5%Receivables 4.0%Inventory 4.7%Fixed assets (tangible) 5.7%Long-term investments 1.0%Other assets 75.1%
How it's funded — Mar 2026
Short-term debt 46.3%Long-term debt 1.5%Payables 7.0%Other liabilities 9.1%Shareholders' equity 36.1%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 10,425.0 | 17,330.2 | 12,141.8 | 14,120.3 |
| Receivables | 4,418.7 | 11,145.3 | 8,416.7 | 8,522.2 |
| Inventory | 5,181.8 | 3,721.7 | 12,615.2 | 2,888.9 |
| Fixed assets (tangible) | 6,263.1 | 4,957.9 | 3,058.4 | 2,917.4 |
| Intangible assets | 79.8 | 119.5 | 104.8 | 133.1 |
| Long-term investments | 1,060.1 | 846.2 | 793.6 | 533.5 |
| Other assets | 82,861.6 | 78,662.4 | 33,472.2 | 12,803.4 |
| Liabilities & equity | ||||
| Short-term debt | 51,065.8 | 52,158.2 | 22,380.3 | 3,442.9 |
| Long-term debt | 1,616.2 | 497.7 | 8.1 | 16.0 |
| Payables | 7,761.1 | 9,251.1 | 9,230.6 | 7,341.6 |
| Other liabilities | 9,994.0 | 17,862.2 | 10,059.6 | 9,717.3 |
| Shareholders' equity | 39,852.9 | 37,013.9 | 28,924.2 | 21,401.1 |
| Net tangible assets | 39,773.1 | 36,894.5 | 28,819.4 | 21,268.0 |
Nomura Micro Science Co., Ltd. Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 4,363,668,000.0 | -20,202,590,000.0 | -18,662,802,000.0 | 4,681,667,000.0 | — |
| Investing Activities | -1,149,735,000.0 | -2,742,144,000.0 | 386,992,000.0 | 64,812,000.0 | — |
| Financing Activities | -6,908,724,000.0 | 27,178,606,000.0 | 17,451,687,000.0 | -24,904,000.0 | — |